SCM
HURA

Sterling Capital Management’s TuHURA Biosciences HURA Stock Holding History

Sterling Capital Management’s Portfolio HURA Stock Details HURA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		– Sell
-279
Closed -$499 – 3440
2026
Q1 		$499 Buy
279
+112
+67% +$137 ﹤0.01% 3156
2025
Q4 		$126 Buy
167
+105
+169% +$201 ﹤0.01% 3223
2025
Q3 		$154 Hold
62
– – ﹤0.01% 3224
2025
Q2 		$138 Buy
+62
New +$209 ﹤0.01% 3246

Other funds holding HURA

Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Northern Trust
Northern Trust Chicago, Illinois $860B AUM 41.15% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Millennium Management
Millennium Management New York $276B AUM 44.8% 1-Year Est. Return
AQR Capital Management
AQR Capital Management Greenwich, Connecticut $287B AUM 42.33% 1-Year Est. Return
Vanguard Fiduciary Trust
Vanguard Fiduciary Trust Malvern, Pennsylvania $454B AUM
Citadel Advisors
Citadel Advisors Miami, Florida $875B AUM 40.89% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.38T AUM 44.17% 1-Year Est. Return
Jane Street
Jane Street New York $1.21T AUM 78.12% 1-Year Est. Return

Sterling Capital Management's HURA Position: Q2 2026 in Review

Sterling Capital Management sold out of TuHURA Biosciences (HURA) in Q2 2026, closing a stake of 279 shares — an estimated $499 sold.

Sterling Capital Management first reported a position in HURA in Q2 2025 and held it in 4 quarters. The position peaked at $499 in Q1 2026. 89 funds tracked by Wall St. Rank hold HURA as of Q2 2026.

  • Sterling Capital Management reported no remaining TuHURA Biosciences position as of Q2 2026 after selling out during the quarter.
  • Sterling Capital Management sold 279 TuHURA Biosciences shares in Q2 2026, an estimated $499.
  • Sterling Capital Management first reported a position in TuHURA Biosciences in Q2 2025 and held it in 4 quarters.
  • Sterling Capital Management's TuHURA Biosciences position peaked at $499 in Q1 2026.
  • 89 funds tracked by Wall St. Rank held TuHURA Biosciences as of Q2 2026.

Based on Sterling Capital Management's 13F filing for Q2 2026, filed 28 Jul 2026.